1. Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study. Issue 6 (30th November 2022) Authors: Girndt, Matthias; Plüer, Manfred; Dellanna, Frank; Michelsen, Ann K.; Beige, Joachim; Toussaint, Kai; Wehweck, Hubert J.; Koch, Michael; Hafezi Rachti, Syrus; Faust, Justus; Bosselmann, Hans-Peter; Witzke, Oliver; Janssen, Robert S. Journal: Human vaccines & immunotherapeutics Issue: Volume 18:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗